This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A total of 109 transactions in the hospice and home health space involved a hospital and health system from 2014 to 2021, according to market analysis data that The Braff Group shared with Hospice News. The number of deals in 2017 and 2018 hit 20 and 19, respectively, before slumping downward during the pandemic in recent years.
About 30% to 50% of home health and hospice transactions in 2021 involved private equity, according to the M&A advisory firm The Braff Group. With this growing influence comes renewed scrutiny about their impact on patientcare, federal policymakers have indicated. Congress also asking questions. Elizabeth Warren (D-Mass.),
Large payers have also jumped into the home-based care bandwagon. billion acquisition of the home health and hospicecompany LHC Group. In February, the UnitedHealth Group (NYSE: UNH) subsidiary Optum closed its $5.4 Optum subsequently made a bid on Amedisys Inc. This followed Humana Inc.’s s (NYSE: HUM) $5.7
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
2018 
246 
Let's personalize your content